Compare CENN & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CENN | PAVM |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | 107 |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 9.1M |
| IPO Year | 2017 | N/A |
| Metric | CENN | PAVM |
|---|---|---|
| Price | $0.12 | $9.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | ★ 765.2K | 13.7K |
| Earning Date | 05-15-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $31,297,393.00 | N/A |
| Revenue This Year | N/A | $603.94 |
| Revenue Next Year | N/A | $37,368.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 41.75 | N/A |
| 52 Week Low | $0.10 | $0.21 |
| 52 Week High | $1.10 | $28.44 |
| Indicator | CENN | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 49.63 | 52.14 |
| Support Level | $0.10 | $0.38 |
| Resistance Level | $0.13 | $10.98 |
| Average True Range (ATR) | 0.01 | 0.58 |
| MACD | 0.00 | -0.12 |
| Stochastic Oscillator | 49.76 | 62.30 |
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.